What does MEDIMAPI do?

MEDIMAPI is a specialist medical practice in Kapellen. Private Limited, started on 7 January 2016, 1 establishment.

What is the address of MEDIMAPI?

The registered office of MEDIMAPI is located at Doornenlaan 11, 2950 Kapellen.

Is MEDIMAPI still active?

Yes. According to the CBE (29 October 2026) MEDIMAPI is active, legal situation “Normale toestand”, started on 7 January 2016.

Is MEDIMAPI registered on Peppol?

Yes, MEDIMAPI is registered on the Peppol network with ID 0208:0645711776.

What is the enterprise number of MEDIMAPI?

The enterprise number of MEDIMAPI is BE0645711776.

When was MEDIMAPI founded?

MEDIMAPI was founded on 7 January 2016.

Who are the directors of MEDIMAPI?

According to the 2024 annual accounts, the directors of MEDIMAPI are: Marian Piqueur.

Is MEDIMAPI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2016; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did MEDIMAPI make in 2024?

MEDIMAPI posted a profit after taxes of € 362,015 in financial year 2024.

What is the revenue of MEDIMAPI?

As a small company, MEDIMAPI is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 532,619.

MEDIMAPI (Private Limited) - Kapellen - BE0645711776

Dossier MEDIMAPI, printed on 29 October 2026 from databakkes.be/en/0645711776/medimapi. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

MEDIMAPI from Kapellen, company number BE0645711776, closed financial year 2024 with a result of € 362,015 after tax. For that financial year MEDIMAPI recorded a gross margin of € 532,619 and equity of € 2.2 million. Compared with financial year 2023, the result moved from € 231,479 to € 362,015. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.

What it is worth Growing

€ 2.2 million

▲ 20% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 362,015

▲ 56% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 1.4 million

▲ 73% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 2.1 million.

People and assets in 2024

Vehicles and equipment

€ 8,529

▲ 31% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 190

Loans from banks and other lenders, long and short.

Taxes

€ 59,111

▲ 59% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 524,726 Gross margin 2021: € 524,726 First fiscal year in the series	€ 582,066 Gross margin 2022: € 582,066 ▲ 11% vs 2021 (€ 524,726) Favourable step	€ 344,099 Gross margin 2023: € 344,099 ▼ 41% vs 2022 (€ 582,066) Unfavourable step	€ 532,619 Gross margin 2024: € 532,619 ▲ 55% vs 2023 (€ 344,099) Favourable step	▲ 55%
Profit after taxes	€ 370,350 Profit after taxes 2021: € 370,350 First fiscal year in the series	€ 397,027 Profit after taxes 2022: € 397,027 ▲ 7% vs 2021 (€ 370,350) Favourable step	€ 231,479 Profit after taxes 2023: € 231,479 ▼ 42% vs 2022 (€ 397,027) Unfavourable step	€ 362,015 Profit after taxes 2024: € 362,015 ▲ 56% vs 2023 (€ 231,479) Favourable step	▲ 56%
Equity	€ 1,172,110 Equity 2021: € 1,172,110 First fiscal year in the series	€ 1,569,136 Equity 2022: € 1,569,136 ▲ 34% vs 2021 (€ 1,172,110) Favourable step	€ 1,800,616 Equity 2023: € 1,800,616 ▲ 15% vs 2022 (€ 1,569,136) Favourable step	€ 2,162,630 Equity 2024: € 2,162,630 ▲ 20% vs 2023 (€ 1,800,616) Favourable step	▲ 20%
Total debts	€ 42,089 Total debts 2021: € 42,089 First fiscal year in the series	€ 51,883 Total debts 2022: € 51,883 ▲ 23% vs 2021 (€ 42,089) Unfavourable step	€ 38,991 Total debts 2023: € 38,991 ▼ 25% vs 2022 (€ 51,883) Favourable step	€ 59,301 Total debts 2024: € 59,301 ▲ 52% vs 2023 (€ 38,991) Unfavourable step	▲ 52%
Cash	€ 1,092,040 Cash 2021: € 1,092,040 First fiscal year in the series	€ 1,501,549 Cash 2022: € 1,501,549 ▲ 37% vs 2021 (€ 1,092,040) Favourable step	€ 834,123 Cash 2023: € 834,123 ▼ 44% vs 2022 (€ 1,501,549) Unfavourable step	€ 1,446,103 Cash 2024: € 1,446,103 ▲ 73% vs 2023 (€ 834,123) Favourable step	▲ 73%
Retained profit	€ 1,153,510 Retained profit 2021: € 1,153,510 First fiscal year in the series	€ 1,550,536 Retained profit 2022: € 1,550,536 ▲ 34% vs 2021 (€ 1,153,510) Favourable step	€ 1,782,016 Retained profit 2023: € 1,782,016 ▲ 15% vs 2022 (€ 1,550,536) Favourable step	€ 2,144,030 Retained profit 2024: € 2,144,030 ▲ 20% vs 2023 (€ 1,782,016) Favourable step	▲ 20%
Dividend	€ 335,782 Dividend 2021: € 335,782 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 335,782) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 190 Bank debt 2024: € 190 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 1,214,199 Balance sheet total 2021: € 1,214,199 First fiscal year in the series	€ 1,621,019 Balance sheet total 2022: € 1,621,019 ▲ 34% vs 2021 (€ 1,214,199) Unchanged	€ 1,839,607 Balance sheet total 2023: € 1,839,607 ▲ 13% vs 2022 (€ 1,621,019) Unchanged	€ 2,221,931 Balance sheet total 2024: € 2,221,931 ▲ 21% vs 2023 (€ 1,839,607) Unchanged	▲ 21%

Key figures of MEDIMAPI, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to MEDIMAPI?

What happened at MEDIMAPI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2025 New annual accounts for financial year 2024: profit of € 362,015 (▲ 56% vs 2023). filed late Source: NBB ↗
Jan 7, 2016 New establishment in Antwerpen. KBO
Jan 7, 2016 Start of the company according to the CBE. KBO

In short

From € 370,350 profit in 2021 to € 362,015 profit in 2024.

Paid € 623,833 in corporate taxes since 2021.

Best year ever: 2022, with € 397,027 profit.

Paid out € 335,782 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Marian Piqueur

MEDIMAPI

Klinisch Biologen ZAS

Behind MEDIMAPI is Marian Piqueur. Marian Piqueur is also behind Klinisch Biologen ZAS.

Directors

According to the 2024 annual accounts

Marian Piqueur

Director

Also active at: Klinisch Biologen ZAS

Establishments

Establishment units

Physical locations of this company

Registered office

Doornenlaan 11

2950 Kapellen

2.261.327.841

Rucaplein 169

2610 Antwerpen

Active since 7 January 2016

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0645.711.776
VAT number: BE 0645.711.776
Registered office: Doornenlaan 11, 2950 Kapellen
Names & denominations: MEDIMAPI
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 January 2016
Peppol: Active · Active since 18 Jun 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗